Search results
What’s going on with the ImmunityBio (IBRX) stock price?
Invezz· 3 days agoImmunityBio (NASDAQ: IBRX) stock price has gone parabolic as investors cheer the recent approval of...
Fed likely to hint interest rates will stay higher for longer. But how high for how long?
USA TODAY via Yahoo Finance· 3 days agoBut Powell could downplay the relevance of the Fed’s March forecasts, signaling that three rate cuts...
5 Things to Know Before the Stock Market Opens
Investopedia· 7 days agoU.S. stock futures are pointing higher on the back of Microsoft's and Alphabet's blowout earnings.
Options traders ‘did not take Powell completely at his word’ on an unlikely chance of a rate hike
Market Watch· 8 hours agoOptions traders have been covering the risks of both a rate hike and multiple rate cuts. As far back...
What is behind the insulin shortage in the US?
Al Jazeera· 9 hours agoIn the past month, she learned that there would be a 30-to-60-day delay in receiving her medication Humalog, an insulin drug made by Eli Lilly. While...
Apple Can Bounce Back
GuruFocus.com via Yahoo Finance· 3 days agoLastly, with a persistent forecast for long-term earnings growth, Apple makes a strong case for investors looking for sustained returns from this global...
Earnings call: Lantheus reports robust growth, eyes $1B in PYLARIFY sales
Investing.com· 20 hours agoLantheus (NASDAQ: LNTH ) Holdings, Inc. (ticker: LNTH), a leader in diagnostic and therapeutic...
Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
Barrons.com· 14 hours agoNovo Nordisk hikes guidance as sales of weight-loss drugs surge, Qualcomm profit lifted amid high...
Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains.
Barrons.com· 3 days agoThe pharmaceutical company reported adjusted earnings of $2.58 a share for the first quarter of...
GBP/USD Forecast: Pound Sterling stays below key resistance levels
The Forex Market· 3 days agoGBP/USD retreated slightly after touching its highest level in over two weeks. The technical outlook...
